SERA PROGNOSTICS, INC. (SERA) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Win; Revenue growth Lose; EPS growth Lose.
17/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 1 wins, 11 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseSERA / S&P -10.34% / 15.20% |
LoseSERA / S&P -35.19% / 15.00% |
LoseSERA / S&P -21.18% / 50.40% |
| 2026-Q10/3 |
LoseSERA / S&P -31.19% / -4.33% |
LoseSERA / S&P -50.43% / 11.30% |
LoseSERA / S&P -30.85% / 27.70% |
| 2025-Q40/3 |
LoseSERA / S&P -3.59% / 2.65% |
LoseSERA / S&P 5.19% / 9.00% |
LoseSERA / S&P -31.31% / 13.40% |
| 2025-Q31/3 |
WinSERA / S&P 10.47% / 8.12% |
LoseSERA / S&P 1.06% / 4.61% |
LoseSERA / S&P -22.22% / 13.45% |
| 2025-Q20/3 |
LoseSERA / S&P -24.73% / 10.94% |
LoseSERA / S&P 0.93% / 4.83% |
LoseSERA / S&P -13.27% / 10.63% |
| 2025-Q10/3 |
LoseSERA / S&P -54.79% / -4.27% |
LoseSERA / S&P -44.17% / 4.98% |
LoseSERA / S&P -12.15% / 10.57% |
| 2024-Q41/3 |
WinSERA / S&P 4.36% / 2.41% |
LoseSERA / S&P -74.84% / 5.25% |
LoseSERA / S&P -14.66% / 6.15% |
| 2024-Q31/3 |
WinSERA / S&P 31.76% / 5.89% |
LoseSERA / S&P -71.52% / 5.89% |
LoseSERA / S&P -19.51% / 6.11% |
| 2024-Q20/3 |
LoseSERA / S&P -34.95% / 4.28% |
LoseSERA / S&P -71.47% / 5.38% |
LoseSERA / S&P -27.41% / 5.12% |
| 2024-Q11/3 |
WinSERA / S&P 52.17% / 10.56% |
LoseSERA / S&P -37.58% / 5.71% |
LoseSERA / S&P -22.46% / 5.59% |
| 2023-Q42/3 |
WinSERA / S&P 221.51% / 11.69% |
WinSERA / S&P 14.18% / 6.81% |
LoseSERA / S&P -19.44% / 7.78% |
| 2023-Q32/3 |
LoseSERA / S&P -43.55% / -3.27% |
WinSERA / S&P 44.10% / 7.52% |
WinSERA / S&P 8.85% / -5.03% |
| 2023-Q22/3 |
LoseSERA / S&P -13.97% / 8.74% |
WinSERA / S&P 127.27% / 9.50% |
WinSERA / S&P 15.38% / -8.57% |
| 2023-Q12/3 |
WinSERA / S&P 203.97% / 7.50% |
WinSERA / S&P 208.41% / 10.77% |
LoseSERA / S&P -65.24% / -15.69% |
| 2022-Q41/3 |
LoseSERA / S&P -21.25% / 7.56% |
WinSERA / S&P 226.83% / 11.88% |
LoseSERA / S&P -79.78% / -17.99% |
| 2022-Q32/3 |
WinSERA / S&P -2.44% / -4.88% |
WinSERA / S&P 269.35% / 13.47% |
LoseSERA / S&P -89.15% / -1.41% |
| 2022-Q21/3 |
LoseSERA / S&P -56.73% / -16.10% |
WinSERA / S&P 275.00% / 13.71% |
LoseSERA / S&P -91.22% / 11.04% |
| 2022-Q11/3 |
LoseSERA / S&P -44.83% / -4.60% |
WinSERA / S&P 256.67% / 15.97% |
LoseSERA / S&P SERA unavailable / 42.23% |
| 2021-Q40/3 |
LoseSERA / S&P -38.16% / 11.03% |
LoseSERA / S&P SERA unavailable / 15.00% |
LoseSERA / S&P SERA unavailable / 96.40% |
| 2021-Q30/3 |
LoseSERA / S&P SERA unavailable / 0.58% |
LoseSERA / S&P SERA unavailable / 10.77% |
LoseSERA / S&P SERA unavailable / 69.42% |
| 2021-Q20/3 |
LoseSERA / S&P SERA unavailable / 8.55% |
LoseSERA / S&P SERA unavailable / 6.58% |
LoseSERA / S&P SERA unavailable / 51.81% |
| 2021-Q10/3 |
LoseSERA / S&P SERA unavailable / 6.17% |
LoseSERA / S&P SERA unavailable / -1.06% |
LoseSERA / S&P SERA unavailable / 7.39% |
| 2020-Q40/3 |
LoseSERA / S&P SERA unavailable / 12.15% |
LoseSERA / S&P SERA unavailable / -3.72% |
LoseSERA / S&P SERA unavailable / -33.42% |
| 2020-Q30/3 |
LoseSERA / S&P SERA unavailable / 8.93% |
LoseSERA / S&P SERA unavailable / -2.04% |
LoseSERA / S&P SERA unavailable / -27.10% |
| 2020-Q20/3 |
LoseSERA / S&P SERA unavailable / 20.54% |
LoseSERA / S&P SERA unavailable / -0.46% |
LoseSERA / S&P SERA unavailable / -27.11% |
| 2020-Q10/3 |
LoseSERA / S&P SERA unavailable / -19.60% |
LoseSERA / S&P SERA unavailable / 3.47% |
LoseSERA / S&P SERA unavailable / -14.75% |
| 2019-Q40/3 |
LoseSERA / S&P SERA unavailable / 9.07% |
LoseSERA / S&P SERA unavailable / 5.36% |
LoseSERA / S&P SERA unavailable / 2.99% |
| 2019-Q30/3 |
LoseSERA / S&P SERA unavailable / 1.70% |
LoseSERA / S&P SERA unavailable / 5.02% |
LoseSERA / S&P SERA unavailable / 0.21% |
| 2019-Q20/3 |
LoseSERA / S&P SERA unavailable / 4.30% |
LoseSERA / S&P SERA unavailable / 6.64% |
LoseSERA / S&P SERA unavailable / 8.65% |
| 2019-Q10/3 |
LoseSERA / S&P SERA unavailable / 13.65% |
LoseSERA / S&P SERA unavailable / 8.12% |
LoseSERA / S&P SERA unavailable / 14.29% |
| 2018-Q40/3 |
LoseSERA / S&P SERA unavailable / -13.52% |
LoseSERA / S&P SERA unavailable / 9.05% |
LoseSERA / S&P SERA unavailable / 18.23% |
| 2018-Q30/3 |
LoseSERA / S&P SERA unavailable / 7.71% |
LoseSERA / S&P SERA unavailable / 10.21% |
LoseSERA / S&P SERA unavailable / 19.06% |
| 2018-Q20/3 |
LoseSERA / S&P SERA unavailable / 3.43% |
LoseSERA / S&P SERA unavailable / 9.03% |
LoseSERA / S&P SERA unavailable / 14.46% |
| 2018-Q10/3 |
LoseSERA / S&P SERA unavailable / -0.76% |
LoseSERA / S&P SERA unavailable / 7.68% |
LoseSERA / S&P SERA unavailable / 12.46% |
| 2017-Q40/3 |
LoseSERA / S&P SERA unavailable / 6.64% |
LoseSERA / S&P SERA unavailable / 7.03% |
LoseSERA / S&P SERA unavailable / 13.82% |
| 2017-Q30/3 |
LoseSERA / S&P SERA unavailable / 4.48% |
LoseSERA / S&P SERA unavailable / 5.68% |
LoseSERA / S&P SERA unavailable / 17.57% |
| 2017-Q20/3 |
LoseSERA / S&P SERA unavailable / 3.09% |
LoseSERA / S&P SERA unavailable / 4.83% |
LoseSERA / S&P SERA unavailable / 17.74% |
| 2017-Q10/3 |
LoseSERA / S&P SERA unavailable / 6.07% |
LoseSERA / S&P SERA unavailable / 3.67% |
LoseSERA / S&P SERA unavailable / 13.32% |
| 2016-Q40/3 |
LoseSERA / S&P SERA unavailable / 3.82% |
LoseSERA / S&P SERA unavailable / 2.09% |
LoseSERA / S&P SERA unavailable / 7.05% |
| 2016-Q30/3 |
LoseSERA / S&P SERA unavailable / 3.85% |
LoseSERA / S&P SERA unavailable / 0.20% |
LoseSERA / S&P SERA unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | SERA total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -37.15% | 20.78% |
| Annualized return | -37.15% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | SERA total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -78.43% | 83.14% |
| Annualized return | -26.42% | 12.86% |
10Y · 2021-07-15 to 2026-08-27
| Metric | SERA total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -82.94% | 319.30% |
| Annualized return | -16.21% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |